Advertisement
Home Tags Prescription Drugs

Tag: Prescription Drugs

L-carnitine appears to be safe and effective for reducing muscle cramps in patients with cirrhosis

L-Carnitine May Reduce Muscle Cramps in Patients With Cirrhosis

0
Dose-dependent effect seen, with greater reduction tied to 1,200 mg/day
Treatment costs for one childhood illness

Hemophilia Drugs a Big Part of State Medicaid Spending

0
California-based researchers find medications for childhood hemophilia take up large share of budget
A new prescription treatment for rosacea was approved on Monday by the U.S. Food and Drug Administration.

FDA Approves New Topical Treatment for Rosacea

0
Finacea Foam is expected to be available by prescription only beginning in September
Tyrosine kinase inhibitors appear to be safe in patients with chronic-phase chronic myeloid leukemia and chronic kidney disease

Tyrosine Kinase Inhibitors Seem Safe in CML With CKD

0
In these patients, no further decline in GFR, regardless of TKI used
Confusion between the names of the antidepressant Brintellix (vortioxetine) and the antiplatelet Brilinta (ticagrelor) has led to the wrong medication being prescribed or dispensed

FDA Warns of Confusion Between Brintellix, Brilinta

0
No known use of the wrong drug, but prescribing, dispensing errors have been reported
Tamsulosin can boost the passage of large kidney stones

Tamsulosin Could Help Passage of Larger Kidney Stones

0
Especially helpful with larger stones, while smaller ones may pass on their own
Led by the American Medical Association

U.S. Medical Groups Fighting Prescription Opioid Abuse

0
Special Task Force aims to curb 'epidemic' of addiction to opioids such as Oxycontin, Vicodin
An experimental drug

New Drug Effectively Lowers Levels of Triglycerides

0
But it's not yet ready for standard care
The selective Hedgehog antagonist PF-04449913 seems safe and is tolerated in adults with myeloid malignancies

New Rx for Myeloid Malignancies Moves to Phase II Clinical Trials

0
Phase I trial involving 47 patients identified maximum tolerated dose of 400 mg once daily
For canagliflozin-treated patients with type 2 diabetes

Low Incidence of Diabetic Ketoacidosis With Canagliflozin

0
Canagliflozin-treated patients with type 2 diabetes have low incidence of serious adverse DKA events